The lincomycin resistance conferred by LmrS is further supported by an amino acid sequence similarity of 62% with the lincomycin resistance protein LmrB of Bacillus subtilis.
LmrS confers clinical levels of resistance to linezolid and fusidic acid, two important antimicrobials with strong activity against MRSA.